Search
Search Results
##search.searchResults.foundPlural##
-
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2905PDF: 1115HTML: 3036 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1788PDF: 583HTML: 289 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2582PDF: 1171HTML: 145 -
COMPARATIVE ANALYSIS OF CLINICAL AND LABORATORY DATA IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2 IN THE REPUBLIC OF KAZAKHSTAN MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2
1016PDF: 576HTML: 341 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
995PDF: 542HTML: 729 -
Bilateral Pleural Effusions due to Pulmonary Amyloidosis as the Presenting Manifestation of Multiple Myeloma
1319PDF: 773HTML: 4389Figure 1: 161Untitled: 137Untitled: 190 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
1805PDF: 1087HTML: 258 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2489HTML: 281PDF: 891 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1117PDF: 1085HTML: 452 -
PERSISTENT COLONIC SCHISTOSOMIASIS AMONG SYMPTOMATIC RURAL INHABITANTS IN THE EGYPTIAN NILE DELTA Colonic schistosomiasis among rurals of the Egyptian Nile delta
1563PDF: 494MP4: 425Html: 197 -
-
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2262PDF: 989HTML: 5073Cover Letter: 173Figure 2: 168Figure 1: 178Figure 3: 200Figure 4: 174Figure Legend: 190Table 1: 195Table 2: 187Table 3: 187 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1073PDF: 723HTML: 80 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1419PDF: 1327HTML: 101 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4411PDF: 927HTML: 1331Table1: 186 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
3593PDF: 1931HTML: 245 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1532PDF: 554HTML: 744 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1090PDF: 968HTML: 341







